Please assess the completion status of the following clinical trial:

Trial Title: Study of Medication Patch to Treat Children Ages 6-12 With ADHD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female outpatients 6 to 12 years of age.~* Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD), by DSM-IV, as manifested in clinical evaluation and confirmed by structured interview.~* Participation in structured morning routine (e.g. school, camp, or other organized activities).~Exclusion Criteria:~* Mental retardation (IQ \<75).~* Subjects with a medical condition, or treatment that will either jeopardize subject safety or affect the scientific merit of the study.~* Subjects with moderate to severe dermatological atopy.~* Subjects with known structural cardiac abnormalities.~* Organic brain disorders.~* Seizure Disorder.~* Subjects with Tourette's syndrome, or a history of psychosis or bipolar disorder.~* Subjects with current comorbid psychopathology that in the investigator's opinion will warrant immediate treatment or will interfere with the safe execution of the protocol (i.e. Anxiety or Major Depressive Disorder rated as moderate on CGI).~* Subjects with a history of intolerable adverse effects or non-response to methylphenidate.~* Pregnant or nursing females.

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Methylphenidate Transdermal System (MTS) (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).